These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 34072586)
21. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer. Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534 [TBL] [Abstract][Full Text] [Related]
22. IL-19 Contributes to the Development of Nonalcoholic Steatohepatitis by Altering Lipid Metabolism. Azuma YT; Fujita T; Izawa T; Hirota K; Nishiyama K; Ikegami A; Aoyama T; Ike M; Ushikai Y; Kuwamura M; Fujii H; Tsuneyama K Cells; 2021 Dec; 10(12):. PubMed ID: 34944021 [TBL] [Abstract][Full Text] [Related]
23. Choline-deficient, high-fat diet-induced MASH in Göttingen Minipigs: characterization and effects of a chow reversal period. Hvid H; Hjuler ST; Bedossa P; Tiniakos DG; Kamzolas I; Harder LM; Xue Y; Perfield JW; Kirk RK; Latta M; Mikkelsen LF; Pedersen HD; Am J Physiol Gastrointest Liver Physiol; 2024 Oct; 327(4):G571-G585. PubMed ID: 39041677 [TBL] [Abstract][Full Text] [Related]
24. The protective effects of Ninjin'yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse. Takano K; Kaneda M; Aoki Y; Fujita N; Chiba S; Michihara S; Han LK; Takahashi R J Nat Med; 2024 Jun; 78(3):514-524. PubMed ID: 38498120 [TBL] [Abstract][Full Text] [Related]
25. HWL-088, a new and highly effective FFA1/PPARδ dual agonist, attenuates nonalcoholic steatohepatitis by regulating lipid metabolism, inflammation and fibrosis. Hu L; Zhou Z; Deng L; Ren Q; Cai Z; Wang B; Li Z; Wang G J Pharm Pharmacol; 2020 Nov; 72(11):1564-1573. PubMed ID: 32734608 [TBL] [Abstract][Full Text] [Related]
26. Effect of methionine/choline-deficient diet and high-fat diet-induced steatohepatitis on mitochondrial homeostasis in mice. Arao Y; Kawai H; Kamimura K; Kobayashi T; Nakano O; Hayatsu M; Ushiki T; Terai S Biochem Biophys Res Commun; 2020 Jun; 527(2):365-371. PubMed ID: 32284169 [TBL] [Abstract][Full Text] [Related]
27. Myeloid AMPK signaling restricts fibrosis but is not required for metformin improvements during CDAHFD-induced NASH in mice. Nunes JRC; O'Dwyer C; Ghorbani P; Smith TKT; Chauhan S; Robert-Gostlin V; Girouard MD; Viollet B; Foretz M; Fullerton MD J Lipid Res; 2024 Jun; 65(6):100564. PubMed ID: 38762124 [TBL] [Abstract][Full Text] [Related]
28. Deletion of TRPC3 or TRPC6 Fails to Attenuate the Formation of Inflammation and Fibrosis in Non-alcoholic Steatohepatitis. Nishiyama K; Toyama C; Kato Y; Tanaka T; Nishimura A; Nagata R; Mori Y; Nishida M Biol Pharm Bull; 2021; 44(3):431-436. PubMed ID: 33642551 [TBL] [Abstract][Full Text] [Related]
30. Knockout of Purinergic P2Y Nishiyama K; Ariyoshi K; Nishimura A; Kato Y; Mi X; Kurose H; Kim SG; Nishida M Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835211 [TBL] [Abstract][Full Text] [Related]
31. A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition. Krishnan A; Abdullah TS; Mounajjed T; Hartono S; McConico A; White T; LeBrasseur N; Lanza I; Nair S; Gores G; Charlton M Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G666-G680. PubMed ID: 28232454 [TBL] [Abstract][Full Text] [Related]
33. Comprehensive characterization of metabolic, inflammatory and fibrotic changes in a mouse model of diet-derived nonalcoholic steatohepatitis. Kim MB; Lee Y; Bae M; Kang H; Pham TX; Hu S; Lee JY; Park YK J Nutr Biochem; 2020 Nov; 85():108463. PubMed ID: 32891893 [TBL] [Abstract][Full Text] [Related]
34. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis. Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211 [TBL] [Abstract][Full Text] [Related]
35. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet. Ding Y; Sun X; Chen Y; Deng Y; Qian K Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348 [TBL] [Abstract][Full Text] [Related]
36. Molecular drivers of non-alcoholic steatohepatitis are sustained in mild-to-late fibrosis progression in a guinea pig model. Ipsen DH; Skat-Rørdam J; Tsamouri MM; Latta M; Lykkesfeldt J; Tveden-Nyborg P Mol Genet Genomics; 2019 Jun; 294(3):649-661. PubMed ID: 30759275 [TBL] [Abstract][Full Text] [Related]
37. Vitamin B5 and N-Acetylcysteine in Nonalcoholic Steatohepatitis: A Preclinical Study in a Dietary Mouse Model. Machado MV; Kruger L; Jewell ML; Michelotti GA; Pereira Tde A; Xie G; Moylan CA; Diehl AM Dig Dis Sci; 2016 Jan; 61(1):137-48. PubMed ID: 26403427 [TBL] [Abstract][Full Text] [Related]
39. Dynamics of oxidative/nitrosative stress in mice with methionine-choline-deficient diet-induced nonalcoholic fatty liver disease. Jorgačević B; Mladenović D; Ninković M; Prokić V; Stanković MN; Aleksić V; Cerović I; Vukićević RJ; Vučević D; Stanković M; Radosavljević T Hum Exp Toxicol; 2014 Jul; 33(7):701-9. PubMed ID: 24130212 [TBL] [Abstract][Full Text] [Related]
40. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation. Chung HK; Kim YK; Park JH; Ryu MJ; Chang JY; Hwang JH; Lee CH; Kim SH; Kim HJ; Kweon GR; Kim KS; Shong M Liver Int; 2015 Apr; 35(4):1341-53. PubMed ID: 25443620 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]